Molecular Partners is a clinical-stage biotechnology company based in Switzerland that designs and develops a class of small engineered proteins known as DARPins. These proteins are built to bind specific molecular targets and are studied as alternatives to conventional antibodies. The company works on therapeutic candidates in areas such as oncology and eye disease, often in partnership with larger pharmaceutical firms, and its customers and collaborators are mainly drug developers and research organisations.
On this site Molecular Partners AG appears as a stock on the London Stock Exchange (UK), code 0QXX, with prices in pounds sterling (GBP). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #2746 of 3788 on the London Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
37/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-8.5%
From 52-week high-22.8%
MomentumWeak
47/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-5.2%
6-month return-10.1%
12-month, skipping last month23.3%
Stability (higher is calmer)Weak
46/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)43.9%
Worst drawdown, 1 year (smaller is calmer)-26.4%
LiquidityWeak
9/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.00M GBP
Zero-volume days13.3%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 2.800 – 3.940Daily closes, split-adjusted
Signals
50-day average3.299
200-day average3.323
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.072
Technical summary
Daily
Strongly bearish
3 bullish · 1 neutral · 12 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
1 bullish · 1 neutral · 6 bearish
Moving averages (daily)
SMA 10
3.18
Bearish
EMA 10
3.14
Bearish
SMA 20
3.26
Bearish
EMA 20
3.22
Bearish
SMA 50
3.30
Bearish
EMA 50
3.27
Bearish
SMA 100
3.21
Bearish
EMA 100
3.27
Bearish
SMA 200
3.32
Bearish
EMA 200
3.30
Bearish
Oscillators (daily)
RSI (14)
38.11
Neutral
MACD (12, 26)
-0.08
Bearish
Momentum (12)
-6.75
Bearish
Stochastic %K (14)
18.60
Bullish
Williams %R (14)
-81.40
Bullish
CCI (20)
-123.4
Bullish
Pivot points (classic, last session)
S3
3.04
S2
3.04
S1
3.04
Pivot
3.04
R1
3.04
R2
3.04
R3
3.04
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in GBP. Educational only, not financial advice.
